mapping the effectiveness and risks of glp-1 receptor agonists pdf Exploring the Science and Practice

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1c targets

Side effects included nausea (44%), vomiting (24%), diarrhea (30%), constipation (24%), abdominal pain (20%), headache (14%), fatigue (11%), dizziness (8%), abdominal distension (7%), and belching (7%)

Weight management can be influenced by many non-modifiable factors like genetic predispositions, age, and ethnicity

These medications affect dopamine (happy chemical) release in the brain, altering reward pathway processes

In terms of side effect profile, gastrointestinal disorders are one of the most common reasons for discontinuing treatment with GLP analogs in adolescents[10,11,15,16]

To address this, a correlation coefficient ( r ) of 0.5 was used to estimate the mean and SD change in BMI reduction outcome